首页> 美国卫生研究院文献>Drug Design Development and Therapy >Apparent histological changes of adipocytes after treatment with CL 316243 a β-3-adrenergic receptor agonist

【2h】

Apparent histological changes of adipocytes after treatment with CL 316243 a β-3-adrenergic receptor agonist

机译：β-3-肾上腺素受体激动剂CL 316243处理后脂肪细胞的表观组织学变化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and objectivesThe objective of this experiment was to study the effect of CL 316,243 (CL) (a highly selective β3-adrenergic receptor agonist) on cellular changes occurring in retroperitoneal white adipose tissue (RWAT) of lean and obese rats.

机译：背景和目的本实验的目的是研究CL 316,243（CL）（一种高度选择性的β3-肾上腺素能受体激动剂）对瘦和肥胖大鼠腹膜后白色脂肪组织（RWAT）中发生的细胞变化的影响。

著录项

期刊名称 Drug Design Development and Therapy
作者
Masoud Ghorbani; Shahram Teimourian; Reza Farzad; Nabiollah Namvar Asl;
展开▼
作者单位

展开▼
年(卷),期 2015(9),-1
年度 2015
页码 669–676
总页数 8
原文格式 PDF
正文语种
中图分类药学 ; 药物化学 ;
关键词
brown adipose tissue cellularity of adipose tissue obesity thermogenesis uncoupling protein Zucker rats;

机译：棕色脂肪组织;脂肪组织的细胞性;肥胖;生热;解偶联蛋白;Zucker大鼠;

相似文献

外文文献
中文文献
专利

1. Apparent histological changes of adipocytes after treatment with CL 316,243, a ?-3-adrenergic receptor agonist [J] . Masoud Ghorbani, Shahram Teimourian, Reza Farzad, Drug Design, Development and Therapy . 2015 ,第4期

机译：用β-3-肾上腺素能受体激动剂CL 316,243处理后，脂肪细胞的表观组织学变化
2. Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the β3-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes [J] . Anita ?st, Bobby Sahachartsiri, Eva Degerman, The biochemical journal . 2009 ,第3期

机译：胰岛素和β3-肾上腺素受体激动剂CL316243对不同膜区室中脂肪细胞PDE3B的差异调节：小窝蛋白1敲低对大分子信号复合物形成/维持的影响
3. Anti-Obesity Effects of Selective Agonists to the β3-Adrenergic Receptor in Dogs. II. Recruitment of Thermogenic Brown Adipocytes and Reduction of Adiposity after Chronic Treatment with a β3-Adrenergic Agonist [J] . Eiji UCHIDA, Masayoshi NIIYAMA, Masayuki SAITO, The Journal of Veterinary Medical Science . 1998 ,第4期

机译：选择性激动剂对狗中β3-肾上腺素受体的抗肥胖作用。二。 β3-肾上腺素能激动剂慢性治疗后热致褐色脂肪细胞的募集和肥胖的减少
4. Cooperation of β_2- and β_3-adrenergic receptors in hematopoietic progenitor cell mobilization [C] . Simon Mendez-Ferrer, Michela Battista, Paul S. Frenette Conference on Skeletal Biology and Medicine . 2010

机译：β_2-和β-3-肾上腺素能受体在造血祖细胞动员中的合作
5. Peroxisome Proliferator-activated Receptor-γ (PPARγ) Agonists: Potential Novel Treatment for HIV-1 Associated Brain Inflammation [D] . Omeragic, Amila . 2020

机译：过氧化物体增殖物激活受体-γ（PPARγ）激动剂：对HIV-1相关脑炎症的潜在新待遇
6. Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the β3-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes [O] . Faiyaz AHMAD, Rebecka LINDH, Yan TANG, -1

机译：胰岛素和β3-肾上腺素能受体激动剂CL316243不同膜隔室中脂肪细胞PDE3B的差异调节：Caveolin-1敲低对大分子信号络合物形成/维持的影响
7. Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta(3)-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes [O] . Ahmad, Faiyaz, Lindh, Rebecka, Tang, Yan, 2009

机译：胰岛素和β（3） - 肾上腺素能受体激动剂CL316243对不同膜区室中脂肪细胞pDE3B的差异调节：caveolin-1敲低对大分子信号复合物形成/维持的影响
8. Electrospray Encapsulation of Toll-Like Receptor Agonist Resiquimod in Polymer Microparticles for the Treatment of Visceral Leishmaniasis [R] . Duong, AD, Sharma, S, Peine, K J, 2013

机译：聚合物微粒中Toll样受体激动剂瑞喹莫德的电喷雾封装治疗内脏利什曼病

Apparent histological changes of adipocytes after treatment with CL 316243 a β-3-adrenergic receptor agonist

摘要

著录项

相似文献

相关主题

期刊订阅